Form D · Pharmaceuticals
BioMarck Pharmaceuticals Ltd
Durham, NC · CIK 0001318185
Offering snapshot reported Feb 8, 2017 · SEC filing
- Reported sold
- $751K Offering amount: $6M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 30, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 8, 2017 | Initial | $751,320 | No comparison | 8 | SEC filing |
| May 18, 2016 | Initial | $7,000,000 | No comparison | 7 | SEC filing |
| Aug 9, 2012 | Initial | $266,446 | No comparison | 20 | SEC filing |
| Aug 28, 2009 | Amendment | $7,500,000 | No comparison | 115 | SEC filing |
| Apr 20, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-280232
Source: Form D, filed Feb 8, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rajin K. Ahuja | Director |
| Thorsten U. Beyer | Director |
| Ashish C. Bhatia | Director |
| Craig A. Collard | Director |
| Brian Dickson | Executive |
| Ron E. Doggett | Director |
| Michael Enright | Executive |
| Allen F. Gant | Director |
| Robin Henning | Executive |
| Robert P. Kennel | Director |
| Walker Long | Director |
| Mohit Mehrotra | Director |
| Mark W Mueller | Director, Executive |
| Laura Calamos Nasir | Director |
| Kennedy C. O'herron | Director |
| Indu Parikh | Executive |
| Thomas H. Roberg | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2530 Meridian Parkway, Suite 300
Durham, NC, 27713
Durham, NC, 27713